eNeura is an electroceutical company that has developed a portable, non-invasive transcranial magnetic stimulation device for treatment of migraine.
The eNeura SAVI TMS device is currently the only non-drug therapy clinically proven to effectively prevent, reduce, or stop pain associated with migraine with aura, and it does so with no unwanted or serious side effects. The device has received FDA and CE Mark approval, and is available by prescription in the United States and European Union.
Investors 1
| Date | Name | Website |
| - | Catalio Ca... | cataliocap... |
Mentions in press and media 6
| Date | Title | Description | Source |
| 07.02.2018 | Camden Partners Nexus leads Series D funding for eNeura | eNeura, a Baltimore-based company that makes a device to treat migraines, closed a Series D investme... | technical.... |
| 21.12.2017 | Camden Partners’ early-stage venture fund makes final close... | Camden Partners announced the final close of its venture capital fund that is seeking to invest in s... | technical.... |
| 18.03.2015 | Red Owl Analytics lands investment from Blackstone [Startup ... | WHO’S GETTING FUNDED Personal Genome Diagnostics won a contract from the U.S. Department of Veteran... | technical.... |
| 05.09.2014 | eNeura raises $5.8M for home migraine device | Maryland-based migraine devices maker eNeura is closing in on a $6.6 million funding round, with $5.... | massdevice... |
| 29.08.2014 | Funding Daily: A shoe company picks up a big bag of cash on ... | We are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI an... | venturebea... |
| 29.08.2014 | Funding Daily: A shoe company picks up a big bag of cash on ... | Today’s funding deals: JustFab raises $85M JustFab is on a meteoric rise, closing a whopping $85 mi... | venturebea... |